Core Viewpoint - In September, 20 A-share companies announced plans to list in Hong Kong, with several achieving record high stock prices, indicating a trend towards internationalization and capital market expansion [1] Group 1: Company Announcements - Dongshan Precision announced plans to issue H-shares and list on the Hong Kong Stock Exchange to promote its international strategy, benefiting from AI development and new capacity expansion, with its stock price reaching a historical high of 86.33 CNY per share, a 300% increase since April [1] - Huadian Co. also announced plans to issue H-shares and list on the Hong Kong Stock Exchange to optimize its overseas layout and expand financing channels, with its stock price hitting a new high of 84.45 CNY per share, a 264% increase since April [1] - Other companies such as Borui Pharmaceutical and Wufangzhai have also initiated preparations for H-share listings, with Borui making progress in clinical research for its BGM0504 injection [1] Group 2: Industry Developments - The PCB industry is represented by Dongshan Precision and Huadian Co., both of which are leading companies with market capitalizations exceeding 100 billion CNY [1] - Borui Pharmaceutical is advancing its clinical research, while Wufangzhai is preparing for H-share listing, indicating a broader trend of A-share companies seeking international capital [1] - Hai Lan Home is increasing its R&D efforts to enrich its product lineup, and Hai Liang Co. is collaborating with several heat dissipation companies, aiming for breakeven in its copper foil business by 2026 [1]
东山精密、沪电股份等:20家A股公司筹划赴港上市